<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/allregs/css/uswds.min.css">
    <link rel="stylesheet" href="/allregs/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/allregs/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/allregs/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/parts/21CFR1271.html">Part 1271
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 1271.60  What quarantine and other requirements apply before
                            </h3>
                            <p class="depth1"><em>(a)</em> Quarantine. You must keep an HCT/P in quarantine, as defined in Sec. 1271.3(q), until completion of the donor-eligibility determination required by Sec. 1271.50. You must quarantine semen from anonymous donors until the retesting required under Sec. 1271.85(d) is complete.</p><p class="depth1"><em>(b)</em> Identification of HCT/Ps in quarantine. You must clearly identify as quarantined an HCT/P that is in quarantine pending completion of a donor-eligibility determination. The quarantined HCT/P must be easily distinguishable from HCT/Ps that are available for release and distribution.</p><p class="depth1"><em>(c)</em> Shipping of HCT/Ps in quarantine. If you ship an HCT/P before completion of the donor-eligibility determination, you must keep it in quarantine during shipment. The HCT/P must be accompanied by records:</p><p class="depth2"><em>(1)</em> Identifying the donor (e.g., by a distinct identification code affixed to the HCT/P container);</p><p class="depth2"><em>(2)</em> Stating that the donor-eligibility determination has not been completed; and</p><p class="depth2"><em>(3)</em> Stating that the product must not be implanted, transplanted, infused, or transferred until completion of the donor-eligibility determination, except under the terms of paragraph (d) of this section.</p><p class="depth1"><em>(d)</em> Use in cases of urgent medical need. (1) This subpart C does not prohibit the implantation, transplantation, infusion, or transfer of an HCT/P from a donor for whom the donor-eligibility determination is not complete if there is a documented urgent medical need for the HCT/P, as defined in Sec. 1271.3(u).</p><p class="depth2"><em>(1)</em> This subpart C does not prohibit the implantation, transplantation, infusion, or transfer of an HCT/P from a donor for whom the donor-eligibility determination is not complete if there is a documented urgent medical need for the HCT/P, as defined in Sec. 1271.3(u).</p><p class="depth2"><em>(2)</em> If you make an HCT/P available for use under the provisions of paragraph (d)(1) of this section, you must prominently label it ``NOT EVALUATED FOR INFECTIOUS SUBSTANCES,'' and `` WARNING: Advise patient of communicable disease

risks.'' The following information must accompany the HCT/P:</p><p class="depth3"><em>(i)</em> The results of any donor screening required under Sec. 1271.75 that has been completed;</p><p class="depth3"><em>(ii)</em> The results of any testing required under Sec. 1271.80 or 1271.85 that has been completed; and</p><p class="depth3"><em>(iii)</em> A list of any screening or testing required under Sec. 1271.75, 1271.80 or 1271.85 that has not yet been completed.</p><p class="depth2"><em>(3)</em> If you are the establishment that manufactured an HCT/P used under the provisions of paragraph (d)(1) of this section, you must document that you notified the physician using the HCT/P that the testing and screening were not complete.</p><p class="depth2"><em>(4)</em> In the case of an HCT/P used for an urgent medical need under the provisions of paragraph (d)(1) of this section, you must complete the donor-eligibility determination during or after the use of the HCT/P, and you must inform the physician of the results of the determination.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§.
          Code available <a href="https://github.com/anthonygarvan/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5
      </div>
    </div>
  </footer>
  </body>
</html>
